Transplantation Market Size Will Attain USD 27.07 Bn By 2027

The global transplantation market size is projected to surpass around USD 27.07 billion by 2027, growing at a CAGR of 9.5% during forecast period from 2022 to 2027.

Organ transplantation is one of the most important developments in contemporary medicine. A surgical procedure is used to extract an organ or tissue from one person (the organ donor) and implant it into another person (the organ recipient). Organ transplants cannot be carried out without the patient’s consent or the approval of the patient’s family, and if they are, it is regarded as illegal or criminal.

The demand for innovative tissue transplantation products and organ transplantation to treat organ failure is one of the main drivers of market expansion. Organ failure typically results from a variety of causes, including severe trauma, blood loss, poisoning, drug misuse, leukemia, sepsis, and other acute illnesses.

Download a Free Sample Copy of this Report@ https://www.precedenceresearch.com/sample/1047

Market Growth

Increased alcohol and other drug use, together with an unhealthy lifestyle that causes organ deterioration over time, are the main factors behind the expansion of the transplantation market’s revenue. Numerous conditions that can cause organ and tissue failure include cardiovascular disease, diabetes, cancer, renal disease, and Alzheimer’s disease. These conditions affect a sizable portion of the global population.

Growing acceptance of tissue and organ transplantation as a result of ongoing advancements in surgical technology, better healthcare facilities, and raised public awareness of organ donation. The expansion of tissue banks and the creation of technologically sophisticated devices are propelling the market’s revenue growth. The development of novel 3D printing technology intended to produce an organ or tissue that is comparable to the one within the body is anticipated to fuel market revenue growth in the transplantation sector.

Transplantation Market Report Scope

Report Highlights

• Product Insight: A value share of about 58% was accounted for by the sector of tissue products, which generated the most revenue in the global transplantation market in 2019. The expansion of the segment is primarily driven by the notable increase in transplantations for orthopedic soft tissues, bone marrow, cochlear, heart valves, and other organs. The other primary element driving the market’s expansion is the advancement and development of novel transplantation products.
• Application Insights: With a revenue share of around 60% in 2019 and a predicted expansion rate of the fastest during the projection period, the tissue transplantation application segment emerged as the market leader globally in the transplantation market. The most frequent procedures carried out internationally include the replacement of the cornea, skin, heart valves, bones, nerves, tendons, and veins. Furthermore, because to ongoing technical advancements made by key companies and healthcare professionals, the success rate is rising and the post-transplant prognosis is getting better, which is fueling the segment’s revenue growth.
• End-user Insights: With a value share of over 49% in the worldwide transplantation market in 2019, the hospital segment led the market and was expected to continue to do so over the forecast period. This is mostly because hospitals, which serve as the primary health care facilities, are performing an increasing number of tissue and organ transplants. The category of transplant centres is anticipated to experience stable revenue growth throughout the course of the research period. Rising government measures to promote organ donation are also predicted to drive market expansion.

Regional Analysis

According to regional analysis, North America’s transplantation market was responsible for the greatest revenue share in 2021. The market in this region is growing in terms of revenue because to the ongoing development of novel transplantation goods for treatment, a well-developed healthcare system, and rising consumer spending on personal health. During the projection period, the market in Asia Pacific is anticipated to have higher revenue growth. The Asia Pacific transplantation market’s revenue growth is being driven by key companies’ ongoing improvements in transplantation technology in these nations. Throughout the forecast period, the European market is anticipated to grow steadily at a high rate of revenue.

Ask Here for Customization@ https://www.precedenceresearch.com/customization/1047

Market Dynamics

Drivers

Immunosuppressants are frequently bought, which is expected to accelerate market expansion in the near future. Both factors include the rising number of organ transplants performed internationally. The number of transplant surgeries for organs including the kidney, liver, heart, and lungs as well as for tissues is predicted to increase as transplantation technology improves and manufacturers provide new goods. As a result of increased alcohol and other dangerous substance use, poor diet, and other chronic diseases, there is an increase in the incidence of organ failure, which can affect the liver, kidneys, lungs, and many other organs. Transplantation market revenue is increasing because patients need organ transplants to survive. The rise of the market’s revenue is also being driven by technological developments in transplantation procedures.

Restraints

After a transplant operation, recipients are given potent immunosuppressive medications, which makes them more susceptible to infectious infections because their immune is compromised. This can be attributable to the drop-in transplantation rates that has occurred in many nations as a result of the COVID-19 issue. In addition, there are a very small number of organ donors compared to the number of patients who need transplants. The length of human life has risen as a result of advances in medicine and surgery. These astonishing medical technological developments have reduced the number of organ donors available for transplantation as a result of rising survival rates.

Competitive Landscape

Due to the presence of numerous major, small, and medium-sized sellers, the market is highly fragmented. Leading companies in the sector include Zimmer Biomet, Medtronic, and Stryker Corporation. To increase their revenue share in the business, these players engage in product launches, mergers and acquisitions, and regional expansion. Vendors are helped by mergers and acquisitions to broaden their geographic and product offerings. For instance, AbbVie announced the acquisition of Allergan in May 2020 in order to expand its product line and distribution options.

Some of the prominent players in the transplantation market include:

• Arthrex, Inc.
• Abbvie, Inc.
• Teva Pharmaceuticals
• Medtronic PLC
• Zimmer Biomet
• Strykers
• Novartis AG
• BiolifeSolutions, Inc.
• 21st Century Medicine
• Veloxis Pharmaceutical

Market Segmentation

By Product Type

• Immunosuppressive Drugs
• Tissue Products
• Preservation Solution

By Application

• Tissue Transplantation
• Organ Transplantation

By End-use

• Transplant Centers
• Hospitals
• Others

Regional Segmentation

• North America (U.S., Canada, Mexico)
• Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
• Asia-Pacific (China, Japan, India, Southeast Asia and Rest of APAC)
• Latin America (Brazil and Rest of Latin America)
• Middle East and Africa (GCC, North Africa, South Africa, Rest of MEA)

Click Here to View Full Report Table of Contents

Thanks for reading you can also get individual chapter-wise sections or region-wise report versions such as North America, Europe, or the Asia Pacific.

Immediate Delivery Available | Buy This Premium Research Report@ https://www.precedenceresearch.com/checkout/1047

You can place an order or ask any questions, please feel free to contact at sales@precedenceresearch.com | +1 9197 992 333